Clinical trials
Terminated Lymphoma, Mantle-Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioNova Pharmaceuticals (Shanghai) LTD. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 1 |
| MingSight Pharmaceuticals, Inc | 1 |
| Novartis Pharmaceuticals | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Mantle-Cell | 5 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Recurrence | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.